Enclomimed 25

Description

Certainly! Here’s a detailed description of Enclomimed 25 (Enclomiphene citrate) y compris le dosage et le contenu :

Présentation du produit :

Enclomimed 25 is a powerful pharmacological agent classified as a selective modulator of the non-steroidal estrogen receptor. It primarily functions by mitigating the suppressive effects of estrogens on the hypothalamic-pituitary-gonadal axis (HPGA). This action leads to an increase in the secretion of gonadotropins, namely hormone lutéinisante (LH) et hormone folliculo-stimulante (FSH), which subsequently enhances the endogenous production of Testostérone.

Development and Benefits:

Evolving from the well-established Clomiphene, Enclomimed 25 offers improved efficacy and safety for users. This product has demonstrated several significant benefits, including:

• Lowering cholesterol levels
• Increasing testosterone levels
• Enhancing fertility

After ingestion, Enclomimed 25 is absorbed in the intestine, resulting in a substantial increase in the release of LH and FSH. The product’s mechanism is particularly advantageous during scenarios of elevated estrogen levels that can result from certain anabolic steroids, which may lead to conditions such as gynécomastie et rétention d'eau.

The incorporation of Enclomimed 25 during cycles that promote high estrogen levels can effectively bind to estrogen receptors, inhibiting the action of estrogen hormones.

Usage in Hormonal Therapy:

The product is particularly beneficial for individuals undergoing Thérapie post-cycle (PCT) or periods of hormonal suppression due to steroid use, as it stimulates natural testosterone production, counteracting the suppression commonly observed.

Manufacturing Quality:

Deus Medical assures that Enclomimed 25 is manufactured in high-standard pharmaceutical facilities located in Inde, and is not sourced from repackaged powders from China. Additionally, all products are subjected to rigorous testing and certification by European third parties, ensuring compliance with distribution standards across Europe. Enclomimed 25 is conveniently available in a tablet form, securely packaged in practical blisters for ease of use.

Informations sur la posologie :

Dosage will vary based on individual goals and physiologies. A standard recommended dosage typically begins at:

• Start with 6.25mg for the initial days.
• Followed by an increase to 12,5 mg.
• Ultimately, users may progress to the standard therapeutic dose of 25mg.

For those on cycle, a dose of 12.5mg per day has shown to be particularly effective.

This provides a concise yet comprehensive overview of Enclomimed 25, highlighting its functionality, benefits, precautions, and dosage recommendations.

1. Kaminetsky, J., Werner, M., Fontenot, G., & Wiehle, R. D. (2013). Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. Journal of Sexual Medicine, 10(6), 1628-1635. Lien

2. Wiehle, R., Cunningham, G. R., Pitteloud, N., Wike, J., Hsu, K., Fontenot, G. K., & Rosenthal, D. M. (2014). Testosterone restoration by enclomiphene citrate in men with secondary hypogonadism: pharmacodynamics and pharmacokinetics. BJU international, 114(5), 663-671. Lien

3. Kohn, T. P., Louis, M. R., Pickett, S. M., Lindgren, M. C., Kohn, J. R., Pastuszak, A. W., & Lipshultz, L. I. (2018). Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertility and sterility, 109(1), 103-109. Lien

4. Watson, L. M., & Aronica, S. M. (2018). A meta-analysis of clomiphene citrate administration in men with idiopathic oligozoospermia. Fertility and sterility. Lien

5. Zitzmann M, Nieschlag E. (2003). Hormone substitution in male hypogonadism. Molecular and cellular endocrinology, 117, 75-78. Lien

6. Kolodziej, A., Kopeć, W., Mędraś, M. (2005). The role of selective estrogen receptor modulator (SERM) in men with idiopathic oligozoospermia. Endokrynologia polska,